{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:06:24Z","timestamp":1789009584432,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"DOI":"10.1186\/s13643-026-03272-0","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:47:19Z","timestamp":1785116839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of risk factors for post-transarterial chemoembolization syndrome in patients with liver cancer: a systematic review protocol"],"prefix":"10.1186","volume":"15","author":[{"given":"Lei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianjin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinling","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"3","key":"3272_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2022;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"3272_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jhep.2024.10.031","volume":"82","author":"EY Tan","year":"2021","unstructured":"Tan EY, Danpanichkul P, Yong JN, et al. Liver cancer in 2021: global burden of disease study. J Hepatol. 2021;82(5):851\u201360. https:\/\/doi.org\/10.1016\/j.jhep.2024.10.031.","journal-title":"J Hepatol"},{"issue":"15","key":"3272_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512224","volume":"24","author":"B Foglia","year":"2023","unstructured":"Foglia B, Turato C, Cannito S. Hepatocellular carcinoma: latest research in pathogenesis, detection and treatment. Int J Mol Sci. 2023;24(15):12224. https:\/\/doi.org\/10.3390\/ijms241512224.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3272_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cld.2022.08.004","volume":"27","author":"P Ganesan","year":"2023","unstructured":"Ganesan P, Kulik LM. Hepatocellular carcinoma: new developments. Clin Liver Dis. 2023;27(1):85\u2013102. https:\/\/doi.org\/10.1016\/j.cld.2022.08.004.","journal-title":"Clin Liver Dis"},{"issue":"18","key":"3272_CR5","doi-asserted-by":"publisher","first-page":"808","DOI":"10.4254\/wjh.v9.i18.808","volume":"9","author":"JE Song","year":"2017","unstructured":"Song JE, Kim DY. Conventional vs drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma. World J Hepatol. 2017;9(18):808\u201314. https:\/\/doi.org\/10.4254\/wjh.v9.i18.808.","journal-title":"World J Hepatol"},{"key":"3272_CR6","doi-asserted-by":"publisher","unstructured":"Tanaka T. Transarterial chemoembolization for hepatocellular carcinoma: current role and techniques. Interv Radiol (Higashimatsuyama). 2024;10:e20240016. https:\/\/doi.org\/10.22575\/interventionalradiology.2024-0016. Published 2024 Oct 4.","DOI":"10.22575\/interventionalradiology.2024-0016"},{"issue":"12","key":"3272_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15123166","volume":"15","author":"A Lawson","year":"2023","unstructured":"Lawson A, Kamarajah SK, Parente A, et al. Outcomes of transarterial embolisation (TAE) vs. transarterial chemoembolisation (TACE) for hepatocellular carcinoma: a systematic review and meta-analysis. Cancers (Basel). 2023;15(12):3166. https:\/\/doi.org\/10.3390\/cancers15123166.","journal-title":"Cancers (Basel)"},{"key":"3272_CR8","doi-asserted-by":"publisher","DOI":"10.22575\/interventionalradiology.2023-0009","volume":"10","author":"H Higashihara","year":"2023","unstructured":"Higashihara H, Kimura Y, Ono Y, Tanaka K, Tomiyama N. Effective utilization of conventional transarterial chemoembolization and drug-eluting bead transarterial chemoembolization in hepatocellular carcinoma: a guide to proper usage. Interv Radiol (Higashimatsuyama). 2023;10:e20230009. https:\/\/doi.org\/10.22575\/interventionalradiology.2023-0009.","journal-title":"Interv Radiol (Higashimatsuyama)"},{"issue":"4","key":"3272_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3350\/cmh.2017.0111","volume":"23","author":"EW Lee","year":"2017","unstructured":"Lee EW, Khan S. Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma. Clin Mol Hepatol. 2017;23(4):265\u201372. https:\/\/doi.org\/10.3350\/cmh.2017.0111.","journal-title":"Clin Mol Hepatol"},{"issue":"3","key":"3272_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3348\/kjr.2022.0395","volume":"24","author":"HN Lee","year":"2023","unstructured":"Lee HN, Hyun D. Complications related to transarterial treatment of hepatocellular carcinoma: a comprehensive review. Korean J Radiol. 2023;24(3):204\u201323. https:\/\/doi.org\/10.3348\/kjr.2022.0395.","journal-title":"Korean J Radiol"},{"issue":"2","key":"3272_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s12072-010-9165-7","volume":"4","author":"M Omata","year":"2010","unstructured":"Omata M, Lesmana LA, Tateishi R, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 2010;4(2):439\u201374. https:\/\/doi.org\/10.1007\/s12072-010-9165-7.","journal-title":"Hepatol Int"},{"issue":"5","key":"3272_CR12","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/RCT.0000000000001610","volume":"48","author":"G Zandieh","year":"2024","unstructured":"Zandieh G, Yazdaninia I, Afyouni S, et al. Spectrum of imaging findings and complications after hepatic transarterial chemoembolization for liver tumors. J Comput Assist Tomogr. 2024;48(5):701\u201312. https:\/\/doi.org\/10.1097\/RCT.0000000000001610.","journal-title":"J Comput Assist Tomogr"},{"issue":"2","key":"3272_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/hep.29517","volume":"67","author":"F Piscaglia","year":"2018","unstructured":"Piscaglia F, Tovoli F, Pini P, Salvatore V. A new horizon in the prevention of the postembolization syndrome after transcatheter arterial chemoembolization for hepatocellular carcinoma. Hepatology. 2018;67(2):467\u20139. https:\/\/doi.org\/10.1002\/hep.29517.","journal-title":"Hepatology"},{"issue":"12","key":"3272_CR14","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1111\/hpb.12487","volume":"17","author":"MC Mason","year":"2015","unstructured":"Mason MC, Massarweh NN, Salami A, Sultenfuss MA, Anaya DA. Post-embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma. HPB (Oxford). 2015;17(12):1137\u201344. https:\/\/doi.org\/10.1111\/hpb.12487.","journal-title":"HPB (Oxford)"},{"key":"3272_CR15","doi-asserted-by":"publisher","unstructured":"Zhao J, Zou Z, Zheng Q, Liu C. Clinical predictors for liver function impairment and post-embolization syndrome following transcatheter arterial chemoembolization in primary hepatic carcinoma patients: a retrospective study. Am J Cancer Res. 2025;15(5):2259\u20132274. https:\/\/doi.org\/10.62347\/PJVG6340. Published 2025 May 15.","DOI":"10.62347\/PJVG6340"},{"issue":"1","key":"3272_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53711-y","volume":"14","author":"J Bai","year":"2024","unstructured":"Bai J, Huang M, Zhou J, Song B, Hua J, Ding R. Development of a predictive nomogram for postembolization syndrome after transcatheter arterial chemoembolization of hepatocellular carcinoma. Sci Rep. 2024;14(1):3303. https:\/\/doi.org\/10.1038\/s41598-024-53711-y.","journal-title":"Sci Rep"},{"issue":"1","key":"3272_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-024-03427-0","volume":"24","author":"X Wang","year":"2024","unstructured":"Wang X, Wang J, Li J, et al. Effect of skeletal muscle index on post-embolization syndrome of hepatocellular carcinoma after transarterial chemoembolization. BMC Gastroenterol. 2024;24(1):333. https:\/\/doi.org\/10.1186\/s12876-024-03427-0.","journal-title":"BMC Gastroenterol"},{"issue":"09","key":"3272_CR18","first-page":"1844","volume":"29","author":"J Ding","year":"2025","unstructured":"Ding J, Wen LF, Wang QY, Li HB, Li G, Su JW, et al. Risk factors and nomogram model for post - embolization syndrome in patients with primary liver cancer after trans - arterial chemoembolization. Anhui Med Pharm J. 2025;29(09):1844\u20139.","journal-title":"Anhui Med Pharm J"},{"issue":"11","key":"3272_CR19","first-page":"1225","volume":"33","author":"G Mingzhu","year":"2024","unstructured":"Mingzhu G, Kewu H, Guangjing G, Lili L. Analysis of related factors for embolization syndrome after transcatheter arterial chemoembolization. J Interv Radiol. 2024;33(11):1225\u20138.","journal-title":"J Interv Radiol"},{"issue":"05","key":"3272_CR20","first-page":"878","volume":"30","author":"Y Yuxiao","year":"2025","unstructured":"Yuxiao Y, Qinming H, Guowei W, Xiaojing Z. Analysis of risk factors for post - embolization syndrome after TACE in patients with primary hepatocellular carcinoma. Zhejiang J Traumat Surg. 2025;30(05):878\u201380.","journal-title":"Zhejiang J Traumat Surg"},{"issue":"9","key":"3272_CR21","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1007\/s10620-023-08010-3","volume":"68","author":"T Thanakunchai","year":"2023","unstructured":"Thanakunchai T, Hongthanakorn C. Prevalence and risk factors of post-chemoembolization syndrome after chemo-embolization for hepatocellular carcinoma in Thailand. Dig Dis Sci. 2023;68(9):3818\u201323. https:\/\/doi.org\/10.1007\/s10620-023-08010-3.","journal-title":"Dig Dis Sci"},{"key":"3272_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2020;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"3272_CR23","unstructured":"Higgins JPT T J C J. Cochrane handbook for systematic reviews of interventions version 6.5 (updated August 2024)[EB\/OL]. [11.12]. www.cochrane.org\/handbook."},{"key":"3272_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/jre.13405","author":"MC Carra","year":"2025","unstructured":"Carra MC, Romandini P, Romandini M. Risk of bias evaluation of cross-sectional studies: adaptation of the Newcastle-Ottawa scale. J Periodontal Res. 2025. https:\/\/doi.org\/10.1111\/jre.13405.","journal-title":"J Periodontal Res"},{"key":"3272_CR25","doi-asserted-by":"publisher","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. https:\/\/doi.org\/10.1136\/bmj.d5928. Published 2011 Oct 18.","DOI":"10.1136\/bmj.d5928"},{"issue":"1","key":"3272_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/M18-1376","volume":"170","author":"RF Wolff","year":"2019","unstructured":"Wolff RF, Moons KGM, Riley RD, et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med. 2019;170(1):51\u20138. https:\/\/doi.org\/10.7326\/M18-1376.","journal-title":"Ann Intern Med"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-026-03272-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-026-03272-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-026-03272-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:17:58Z","timestamp":1789006678000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13643-026-03272-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3272"],"URL":"https:\/\/doi.org\/10.1186\/s13643-026-03272-0","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"As far as we know, this will be the first study to comprehensively analyze the association between risk factors and the risk of PES. The findings of this review will contribute to future research on PES intervention measures and provide an evidence-based basis. The research results will be summarized and presented through academic conferences and publications in peer-reviewed journals. This study only involves the analysis of data from published literature and does not include personally identifiable information. Therefore, it can be conducted without ethical approval.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"250"}}